Severe acute tubular necrosis observed subsequent to oxaliplatin administration

A 67-year-old man known for metastatic colon cancer received treatment with oxaliplatin and developed severe acute kidney injury requiring dialysis. Renal biopsy revealed severe acute tubular necrosis. Acute kidney injury is a rare but severe adverse effect of oxaliplatin administration.

• Publication year

  2013

• Venue

  Clinical Kidney Journal

• Publication date

  2013-12-29

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/ckj/sft148PMID 25859355PMCID 4389161
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A rare case of acute kidney injury associated with autoimmune hemolytic anemia and thrombocytopenia after long-term usage of oxaliplatin

  2012cited by this paper
• Oxaliplatin-induced proximal renal tubular acidosis

  2010cited by this paper
• Acute renal failure related to oxaliplatin-induced intravascular hemolysis

  2010cited by this paper
• Oxaliplatin-induced acute renal failure presenting clinically as thrombotic microangiopathy: think of acute tubular necrosis

  2009cited by this paper
• Oxaliplatin-induced hemolytic anemia during adjuvant treatment of a patient with colon cancer: a case report.

  2007cited by this paper
• Oxaliplatin-induced immune hemolytic anemia: a case report and review of the literature.

  2007cited by this paper
• Renal tubular acidosis due to oxaliplatin.

  2006cited by this paper
• Hemolytic uremic syndrome following the infusion of oxaliplatin: case report

  2006cited by this paper
• Renal toxicity of oxaliplatin.

  2005cited by this paper
• Oxaliplatin induces a delayed immune-mediated hemolytic anemia: a case report and review of the literature.

  2005cited by this paper
• Phase I study of oxaliplatin in patients with advanced cancer

  2004cited by this paper
• Two potential mechanisms of oxaliplatin-induced haemolytic anaemia in a single patient

  2004cited by this paper
• A case of acute tubular necrosis due to oxaliplatin.

  2002cited by this paper
• Oxaliplatin-induced haemolytic anaemia.

  1999cited by this paper

• Preoperatory FLOT Regimen for Gastroesophageal Cancer and Renal Function: A New Onco-Nephrological Perspective

  2025cites this paper
• Association of Plasma Creatinine with Systemic Exposure to S-1 and Oxaliplatin in Two Types of Chronic Kidney Disease Animal Models.

  2025cites this paper
• Chemotherapy-induced acute kidney injury: epidemiology, pathophysiology, and therapeutic approaches

  2024cites this paper
• Identification Drug Targets for Oxaliplatin-Induced Cardiotoxicity without Affecting Cancer Treatment through Inter Variability Cross-Correlation Analysis (IVCCA)

  2024cites this paper
• Naringin attenuates oxaliplatin‐induced nephrotoxicity and hepatotoxicity: A molecular, biochemical, and histopathological approach in a rat model

  2023cites this paper
• Biopsy-proven first dose of oxaliplatin-induced acute tubular necrosis leading to end-stage renal failure: a case report

  2023cites this paper
• Chronic Kidney Disease Prevalence in Patients with Colorectal Cancer Undergoing Surgery

  2022cites this paper
• Digital ischaemia and necrosis from oxaliplatin

  2022cites this paper
• Sulforaphane has an additive anticancer effect to FOLFOX in highly metastatic human colon carcinoma cells.

  2022cites this paper
• Severe AKI induced by Oxaliplatin: A case report

  2021cites this paper
• Conventional Chemotherapy Nephrotoxicity.

  2021cites this paper
• Management of acute kidney injury in gastrointestinal tumor: An overview

  2021cites this paper
• Nephroprotective Effect of Costus (Saussurea costus) Ethanolic Extract on Oxaliplatin®-induced Nephrotoxicity in Adult Male Wistar Rats.

  2021cites this paper
• A case of biopsy-proven oxaliplatin-induced acute tubulointerstitial nephritis with thrombocytopenia and anemia

  2019cites this paper
• Histopathological and biochemical assessment of kidney damage in albino wistar rats treated with cytotoxic platinum compounds in combination with 5-FU.

  2017cites this paper
• Nephrotoxicity of Chemotherapy Agents

  2015cites this paper